Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

162
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
162
Relative Risk01:12

Relative Risk

303
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
303
Hazard Ratio01:12

Hazard Ratio

220
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
220
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

146
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
146
Data Validation01:03

Data Validation

5.2K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
5.2K
Criteria for Causality: Bradford Hill Criteria - II01:28

Criteria for Causality: Bradford Hill Criteria - II

549
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
549

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histamine risk assessment in Scombridae fish across processing forms and distribution channels: a case study from Nghe An Province, Vietnam.

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2026
Same author

Antipsychotic Drugs and the Risk of Diabetic Complications: A Systematic Review of Observational Studies.

Journal of clinical medicine·2026
Same author

Understanding how adverse childhood experiences influence the development of postpartum post-traumatic stress disorder: a qualitative study in China.

European journal of psychotraumatology·2026
Same author

Antipsychotic Drugs and the Risk of Diabetic Complications: A Systematic Review of Clinical Evidence.

Journal of clinical medicine·2026
Same author

Effects of vaginal microbiota transfer on social-emotional and neurodevelopment in cesarean-born infants: 12-month follow-up of a pilot randomized clinical trial.

Acta obstetricia et gynecologica Scandinavica·2026
Same author

Self-perceived mental health among Canadian adolescents and young adults with asthma: Insights from a national cross-sectional study.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026

Related Experiment Video

Updated: Aug 29, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K

Development of an Evidence-Based Risk Assessment Framework.

Daniel Krewski1,2,3, Patrick Saunders-Hastings2, Robert A Baan4

  • 1School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.

ALTEX
|September 13, 2022
PubMed
Summary

This study proposes an evidence-based framework for human health risk assessment, integrating diverse data streams, including new approach methodologies. The goal is to improve risk characterization for environmental agents, considering all available evidence.

Keywords:
environmental agentsevidence integrationnew approach methodologiespopulation healthrisk assessment

More Related Videos

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Related Experiment Videos

Last Updated: Aug 29, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Area of Science:

  • Toxicology
  • Environmental Health
  • Risk Assessment

Background:

  • Evaluating human health risks from environmental agents requires integrating diverse evidence.
  • New Approach Methodologies (NAMs) in toxicology necessitate updated risk assessment frameworks.
  • Existing methods may not fully incorporate all available data, especially for data-poor agents.

Purpose of the Study:

  • To explore the development of an evidence-based risk assessment framework.
  • To provide guidance on integrating evidence from multiple streams in risk assessment.
  • To ensure all available data is considered for accurate risk characterization.

Main Methods:

  • International workshop with academic, government, and private sector participants.
  • Discussion focused on integrating diverse evidence for risk assessment.
  • Development of a prototype framework for evidence integration.

Main Results:

  • General agreement on key considerations for evidence-based risk assessment.
  • Identification of essential elements for incorporating 21st-century science into risk assessment.
  • A prototype framework for evidence integration was established.

Conclusions:

  • An evidence-based framework is crucial for robust human health risk assessment.
  • Integrating diverse data, including NAMs, enhances risk characterization.
  • The proposed framework will guide future risk assessment practices.